Pacific biosciences of california stock.

Nov 24, 2023 · 11 analysts have issued 1 year price objectives for Pacific Biosciences of California's stock. Their PACB share price targets range from $8.00 to $17.00. On average, they predict the company's stock price to reach $11.80 in the next year. This suggests a possible upside of 38.0% from the stock's current price.

Pacific biosciences of california stock. Things To Know About Pacific biosciences of california stock.

Reassessing Pacific Biosciences: Deep Dive Into Q3 2023 Revenue Surge And Market Dynamics 11/20/23-9:07AM EST Seeking Alpha Pacific Biosciences of California rises after UBS upgrades on strong ...According to the issued ratings of 11 analysts in the last year, the consensus rating for Pacific Biosciences of California stock is Moderate Buy based on the current 3 hold ratings and 8 buy ratings for PACB. The average twelve-month price prediction for Pacific Biosciences of California is $11.80 with a high price target of $17.00 and a low ...Find the latest Pacific Biosciences of California, Inc. (PACB) stock quote, history, news and other vital information to help you with your stock trading and investing.Find the latest Pacific Biosciences of California, Inc. (PACB) stock quote, history, news and other vital information to help you with your stock trading and investing. Home. Mail; News; Sports; Finance; ... Pacific Biosciences of California, Inc. (PACB) NasdaqGS - NasdaqGS Real Time Price. Currency in USD. Add to watchlist. 8.55 +0.19 (+2.27%)Complete Pacific Biosciences of California Inc. stock information by Barron's. View real-time PACB stock price and news, along with industry-best analysis.

١٣‏/٠٩‏/٢٠٢٣ ... Pacific Biosciences of California Stock Clears Key Benchmark, Hitting 80-Plus RS Rating ... The Relative Strength (RS) Rating for Pacific ...Let’s take a look at how Pacific Biosciences of California Inc’s stock performed this quarter. Earnings: $-0.28 per share, versus the consensus estimate of $-0.32 per share, according to AAII’s Stock Investor Pro, Refinitiv and I/B/E/S. Revenue: $39 million, versus $33 million in the same period one year ago.STOCK INFORMATION IRS Notification. Form 8937 Omniome. Stock Quote ... Pacific Biosciences of California, Inc. 1305 O’Brien Drive, Menlo Park, CA 94025

Pacific Biosciences of California, Inc. (NASDAQ:PACB – Get Free Report) gapped up prior to trading on Friday .The stock had previously closed at $6.52, but opened at $6.92. Pacific Biosciences ...Find the latest news headlines from Pacific Biosciences of California, Inc. Common Stock (PACB) at Nasdaq.com.

١٦‏/٠٨‏/٢٠٢٣ ... Why Pacific Biosciences of California Inc's (PACB) Stock Is Down 4.55% ... One of the most dreaded feelings for an investor is when the stock they ...Pacific Biosciences of California Inc Stock , PACB 8.95 +0.07 +0.79% After-market 07:47:07 PM EDT 12/1/2023 NASOct 31, 2023 · PacBio Announces Third Quarter 2023 Financial Results. MENLO PARK, Calif. , Oct. 30, 2023 /PRNewswire/ -- PacBio (NASDAQ: PACB) today announced financial results for the quarter ended September 30, 2023 . Third quarter results Revenue of $55.7 million , a 72% increase compared with $32.3 million in the prior-year period. October 30, 2023. MENLO PARK, Calif., April 29, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) today announced financial results for the quarter ended March 31, 2021.

Get the latest PACB stock quote, news, history and other vital information to help you with your stock trading and investing. See the performance outlook, earnings date, dividend …

Stock analysis for Pacific Biosciences of California Inc (PACB:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

Pacific Biosciences Of California. stock was originally listed at a price of $16.44 in Oct 27, 2010. If you had invested in Pacific Biosciences Of California stock at $16.44 , your return over the last 13 years would have been -47.99% , for an annualized return of -4.9% (not including any dividends or dividend reinvestments).Oct. 31. MT. Morgan Stanley Adjusts Price Target on Pacific Biosciences of California to $10 From $13, Maintains Equal-Weight Rating. Oct. 24. MT. Barclays Cuts Price Target on Pacific Biosciences of California $9 From $14, Maintains Equalweight Rating. Sep. 29. MT. Bernstein Starts Pacific Biosciences of California With Outperform Rating, $11 ...Published: SATURDAY DECEMBER 2, 2023. Pacific Biosciences of California (PACB) stock hit day 0 of a continuous streak of days with losses, with cumulative ...The company's average rating score is 2.73, and is based on 8 buy ratings, 3 hold ratings, and no sell ratings. Price Target Upside/Downside. According to ...٢٥‏/٠٩‏/٢٠٢٣ ... Why Pacific Biosciences of California Inc's (PACB) Stock Is Down 5.37% ... Avoid the stress of overpaying for a stock or missing an opportunity by ...And the warming slowdown. To understand why the west has been so dry since the turn of the century, cast your eye further west—to the natural waxing and waning of Pacific Ocean winds. Strong trade winds have been forcing heat into ocean dep...

١٦‏/٠٨‏/٢٠٢٣ ... Why Pacific Biosciences of California Inc's (PACB) Stock Is Down 4.55% ... One of the most dreaded feelings for an investor is when the stock they ...Jan-26-23 08:52AM. Pacific Biosciences of California (NASDAQ:PACB) shareholder returns have been massive, earning 313% in 5 years. (Simply Wall St.) Jan-24-23 11:18PM. Pacific Biosciences of California, Inc. Announces Pricing of Upsized Public Offering of Common Stock. Let’s take a look at how Pacific Biosciences of California Inc’s stock performed this quarter. Earnings: $-0.28 per share, versus the consensus estimate of $-0.32 per share, according to AAII’s Stock Investor Pro, Refinitiv and I/B/E/S. Revenue: $39 million, versus $33 million in the same period one year ago.See Pacific Biosciences of California, Inc. stock price prediction for 1 year made by analysts and compare it to price changes over time to develop a better trading strategy.Pacific Biosciences of California Inc (NASDAQ: PACB) has seen a rise in its stock price by 10.74 in relation to its previous close of 6.52. However, the company has experienced a 1.55% gain in its stock price over the last five trading sessions. Zacks Investment Research reported 2023-10-31 that PacBio (PACB) witnesses strong revenue growth in ...Find the latest Pacific Biosciences of California, Inc. (PACB) stock quote, history, news and other vital information to help you with your stock trading and investing.See the latest Pacific Biosciences of California Inc stock price (PACB:XNAS), related news, valuation, dividends and more to help you make your investing decisions.

In other news concerning Pacific Biosciences of California, insider Michele Farmer sold 5,165 shares of the company’s stock on May 18th at an average price of $12.59 per share, resulting in a total transaction value of $65,027.35. Following this sale, Farmer now holds 107,577 shares of PACB stock with an approximate value of $1,354,394.43.Industry Rank: Top 29% (74 out of 251) Industry: Medical - Instruments. Pacific Biosciences of California (PACB) Quote Overview » More Research » Pacific Biosciences of California (PACB ...

A steep rise in short interest was recorded in Pacific Biosciences of California Inc stocks on Oct 30, 2023, growing by 2.05 million shares to a total of 35.12 million shares. Yahoo Finance data shows the prior-month short interest on Sep 28, 2023 was 33.07 million shares. There was a rise of 5.84%, which implies that there is a …MENLO PARK, Calif., April 29, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) today announced financial results for the quarter ended March 31, 2021.The Pacific Biosciences of California stock prediction results are shown below and presented as a graph, table and text information. Pacific Biosciences of California stock forecasts are adjusted once a day based on the closing price of the previous trading day. The minimum target price for Pacific Biosciences of California …Interactive Chart for Pacific Biosciences of California, Inc. (PACB), analyze all the data with a huge range of indicators.You can hold this stock in a SIPP, ISA, JISA and Trading Account. Market Cap. $2.030bn. Div. Yield. -. Volume. 6,012,760. Open Price. $8.49. Prev. Close. $8.58.HENRY CHRISTIAN O, the of Pacific Biosciences of California Inc, sale 96,844 shares at $10.12 during a trade that took place back on Sep 18, which means that HENRY CHRISTIAN O is holding 1,106,095 shares at $980,255 based on the most recent closing price. Stock Fundamentals for PACB. Current profitability levels for the company …Pacific Biosciences of California, Inc. (NASDAQ: PACB) is a California-based biotech firm founded in 2004. It is ranked seventh on our list of 10 best biotech stocks to buy according to Cathie Wood.Pacific Biosciences of California Inc. Watch NEW Set a price target alert Premarket Last Updated: Nov 28, 2023 8:00 a.m. EST Delayed quote $ 8.44 0.00 0.00% Before Hours Volume: 1 Advanced...

Pacific Biosciences of California Inc (NASDAQ: PACB) has seen a rise in its stock price by 10.74 in relation to its previous close of 6.52. However, the company has experienced a 1.55% gain in its stock price over the last five trading sessions. Zacks Investment Research reported 2023-10-31 that PacBio (PACB) witnesses strong revenue …

Over the last year, Pacific Biosciences of California, Inc.’s stock price has decreased by 17.39%. Pacific Biosciences of California, Inc. is currently approximately $8.55 per share.

Pacific Biosciences of California Stock Earnings. The value each PACB share was expected to gain vs. the value that each PACB share actually gained. PACB ( PACB) reported Q3 2023 earnings per share (EPS) of -$0.26, beating estimates of -$0.29 by 9.37%. In the same quarter last year, PACB 's earnings per share (EPS) was -$0.34.Pacific Biosciences of California has been profitable 1 over the past 10 years. Over the past twelve months, the company had a revenue of $146.10 million and Loss Per Share of $1.35.Get Pacific Biosciences of California Inc (PACB.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments ... Stocks. Index Last % Change ...Pacific Biosciences of California, Inc. is a life science technology company. The Company designs, develops and manufactures advanced sequencing solutions to help scientists and clinical researchers resolve genetically complex problems. ... Stock Pacific Biosciences of California, Inc. - Nasdaq . News Pacific Biosciences of California, Inc ...These 9 analysts have an average price target of $11.22 versus the current price of Pacific Biosciences at $7.2, implying upside. Below is a summary of how these 9 analysts rated Pacific ...Nov 22, 2023 · The Pacific Biosciences of California stock prediction results are shown below and presented as a graph, table and text information. Pacific Biosciences of California stock forecasts are adjusted once a day based on the closing price of the previous trading day. The minimum target price for Pacific Biosciences of California analysts is $. Today ... The five states that border the Pacific Ocean are California, Oregon, Washington, Alaska and Hawaii. The proximity of the states to the Pacific Ocean affects their climate. Along the coast, temperatures vary by as much as 19 degrees Fahrenh...Nov 27, 2023 · Pacific Biosciences of California Non-GAAP EPS of -$0.35 beats by $0.02, revenue of $27.35M beats by $0.06M SA News Thu, Feb. 16 Pacific Biosciences of California Q4 2022 Earnings Preview MENLO PARK, Calif., Sept. 27, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq: PACB)(“Pacific Biosciences” or “PacBio”), a leading provider of high-quality, highly accurate sequencing platforms, today announced a partnership with The European Reference Genome Atlas (ERGA) consortium to support …Pacific Biosciences of California, Inc. Q4 Loss Increases, but beats estimates. (RTTNews) - Pacific Biosciences of California, Inc. (PACB) released Loss for its fourth quarter that increased from ...

You can hold this stock in a SIPP, ISA, JISA and Trading Account. Market Cap. $2.030bn. Div. Yield. -. Volume. 6,012,760. Open Price. $8.49. Prev. Close. $8.58.Pacific Biosciences of California, Inc. (aka PacBio) is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. [failed verification] PacBio has two principal sequencing platforms: single-molecule real-time sequencing (SMRT), based on the …If you live in California, chances are you get your electricity and gas services from Pacific Gas and Electric Company (PG&E). As a PG&E customer, you receive a monthly bill for your energy usage.Instagram:https://instagram. best pet insurance in njretired military dental planstips tickermanchester united stock value The Pacific Biosciences of California stock prediction results are shown below and presented as a graph, table and text information. Pacific Biosciences of California stock forecasts are adjusted once a day based on the closing price of the previous trading day. The minimum target price for Pacific Biosciences of California …Jan-26-23 08:52AM. Pacific Biosciences of California (NASDAQ:PACB) shareholder returns have been massive, earning 313% in 5 years. (Simply Wall St.) Jan-24-23 11:18PM. Pacific Biosciences of California, Inc. Announces Pricing of Upsized Public Offering of Common Stock. primecap vanguardally stokc Pacific Biosciences of California, Inc. (aka PacBio) is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. [failed verification] PacBio has two principal sequencing platforms: single-molecule real-time sequencing (SMRT), based on the …Pacific Biosciences of California has a 12-month low of $5.74 and a 12-month high of $14.55. The stock has a market capitalization of $2.26 billion, a PE ratio of -6.65 and a beta of 1.72. The company has a debt-to-equity ratio of 1.17, a current ratio of 4.80 and a quick ratio of 4.43. Pacific Biosciences of California ( NASDAQ:PACB – … ishares core us aggregate bond Get the latest Pacific Biosciences of California, Inc. (PACB) stock news and headlines to help you in your trading and investing decisions. ... Pacific Biosciences of California, Inc. (NASDAQ:PACB ...Pacific Biosciences of California Inc. PACB (U.S.: Nasdaq) Pacific Biosciences of California Inc. View All companies. AT CLOSE 1:00 PM EST 11/24/23. $8.55 USD.Pacific Biosciences. Pacific Biosciences of California, Inc. (aka PacBio) is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. [2] [3] [failed verification] PacBio has two principal sequencing platforms: single-molecule real-time ...